All

Seventure Partners Announces First Close of New Fund, Sport & Performance Capital
11 July 2019

Seventure Partners Announces First Close of New Fund, Sport & Performance Capital

Seventure Partners, one of Europe’s leaders in financing innovation in Life sciences and associated industries, announces the launch of Sport & Performance Capital™, a new...

Read the press release
GEFCO acquires Chronotruck to take digitalization to the next level for shippers and carriers
10 July 2019

GEFCO acquires Chronotruck to take digitalization to the next level for shippers and carriers

GEFCO Group announced today the acquisition of Chronotruck, a company that connects shippers and carriers through an innovative digital platform. This acquisition supports...

Read more
Caisse d’Epargne and Seventure Partners launch « Sport & Performance Capital », a French fund dedicated to the economics of sports
4 July 2019

Caisse d’Epargne and Seventure Partners launch « Sport & Performance Capital », a French fund dedicated to the economics of sports

Seventure Partners, one of Europe’s leaders in financing innovation in Life sciences and associated industries, announces the launch of Sport & Performance Capital™, a new...

Read the press release
Seventure Partners Life Sciences Corporate Update Health for Life: March 2019 – June 2019
1 July 2019

Seventure Partners Life Sciences Corporate Update Health for Life: March 2019 – June 2019

Seventure Partners, one of Europe’s leaders in financing innovation and a world-leader in life science microbiome investment, is pleased to provide an update on its Health...

Read the press release
String Bio Raises Capital to Develop and Manufacture Next-Generation Alternative Proteins in India
28 June 2019

String Bio Raises Capital to Develop and Manufacture Next-Generation Alternative Proteins in India

String Bio, a biotechnology company, announced today that it raised capital to develop next-generation alternate proteins for the global feed and food companies. The products...

Read the press release
LiMM Therapeutics incorporated to translate breakthrough science into first in class therapeutic agents
25 June 2019

LiMM Therapeutics incorporated to translate breakthrough science into first in class therapeutic agents

LiMM Therapeutics was created to lead development of a new class of therapeutic agents - neuronal reprogrammers of innate lymphocytes. The company is based on pioneering...

Read the press release
European Venture Capital Firm Seventure Partners renews its support to Domain Therapeutics and invests €3.5M ($3.9M) to prepare the next growth phase
28 May 2019

European Venture Capital Firm Seventure Partners renews its support to Domain Therapeutics and invests €3.5M ($3.9M) to prepare the next growth phase

Domain Therapeutics announces today that it has secured a €3.5M ($3.9M) investment from existing shareholder Seventure Partners, to accelerate its next growth phase. Since...

Read the press release
Vedanta Biosciences Closes Extended $45.5 Million Series C Financing
13 May 2019

Vedanta Biosciences Closes Extended $45.5 Million Series C Financing

Vedanta Biosciences, a clinical-stage company developing a new category of therapies for immune-mediated diseases based on rationally-defined consortia of human...

Read more
Vedanta Biosciences Key Microbiome Patent Upheld in European Opposition Proceedings
8 May 2019

Vedanta Biosciences Key Microbiome Patent Upheld in European Opposition Proceedings

Upheld patent EP2575835 covers therapeutic compositions of clostridial bacterial species derived from the human microbiome. Decision further solidifies Vedanta’s leading IP...

Read more

By continuing your browsing on this site, you accept the use of cookies to carry out statistics of anonymous visits. Read more

Authorize Refuse